Technology
Health
2016 IPO

MYOS RENS

379

$1.19
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.05 (-3.64%) As of 2:58 PM EST today
-$0.05 (-3.64%) Today

Why Robinhood?

You can buy or sell MYOS RENS and other stocks, options, ETFs, and crypto commission-free!

About MYOS

MYOS RENS Technology, Inc. engages in the discovery, development, and commercialization of advanced nutrition products, functional foods, and other technologies aimed at maintaining or improving the health and performance of muscle tissue. Its primary product is Fortetropin, a proprietary bioactive composition derived from fertilized egg yolk, intended to increase lean muscle mass, size, and strength. Read More The company was founded on April 11, 2007 and is headquartered in Cedar Knolls, NJ.

CEO
Joseph Manello
Employees
12
Headquarters
Cedar Knolls, New Jersey
Founded
2007
Market Cap
11.47M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
14.39K
High Today
$1.20
Low Today
$1.19
Open Price
$1.20
Volume
14.24K
52 Week High
$2.02
52 Week Low
$1.15

Collections

Technology
Health
2016 IPO
US
North America

MYOS Earnings

-$0.14
-$0.09
-$0.05
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
— per share
Actual
Expected Mar 25, After Hours

People Also Bought

Geron

31,497

$1.16

+0.87%

Geron

31,497

$1.16

+0.87%

Verastem

17,643

$1.97

-0.25%

Biocept

20,208

$0.3033

+0.33%

TherapeuticsMD

13,705

$1.77

-4.32%

GE

330,169

$10.87

-4.02%

Chesapeake Energy

139,698

$0.3014

-32.10%

Pareteum

29,373

$0.5712

-2.81%

Dare Bioscience

2,685

$1.18

-7.81%

Kitov Pharmaceuticals

1,957

$0.64

-2.19%

AIM ImmunoTech

3,622

$1.12

+6.67%

Moleculin Biotech

3,382

$0.6869

-0.45%

Marinus Pharmaceuticals

5,033

$2.68

-4.80%

You May Also Like

ENR
SSPK
PRT
LPL
CYCC
UMH-B
REX
RYTM
PKG
CTRA
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy MYOS

Market Price$1.19
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell MYOS RENS stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up